NCBI PubMed NLMPubMed
Entrez PubMed Nucleotide Protein Genome Structure OMIM PMC Journals Books
 Search for
  Limits Preview/Index History Clipboard Details    
About Entrez
spacer gif
back to About Entrez
back to About Entrez

Text Version

Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities

PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby

Related Resources
Order Documents
NLM Gateway
TOXNET
Consumer Health
Clinical Alerts
ClinicalTrials.gov
PubMed Central

Privacy Policy

 Show: 

1: Ned Tijdschr Geneeskd. 1998 Jun 27;142(26):1508-11. Related Articles, Links

[Severe tardive dyskinesia during treatment with risperidone and fluoxetine]

[Article in Dutch]

Dubbelman YD, Thung FH, Heeringa M.

Afd. Urologie, Academisch Ziekenhuis Rotterdam-Dijkzigt.

A 26-year-old man with schizophrenia, disorganised type, and depression, developed severe tardive dyskinesia during treatment with risperidone and fluoxetine. In view of the course of the symptoms and the findings in the neurological analysis a causal relation with the use of the these second-generation psychopharmaca was probable. These new-generation psychopharmaca are supposed to have fewer adverse events. Nevertheless, as is illustrated in this case, prescription is not without risk. Especially when using a combination of psychopharmaca, side effects must be monitored carefully.

Publication Types:
  • Case Reports

PMID: 9752071 [PubMed - indexed for MEDLINE]


 Show: